digital dna

Artificial Intelligence Enhances Oncology

The volume of information that needs to be analyzed to make precision medicine a reality in cancer care is often beyond the realm of the human mind. That’s where artificial intelligence steps in
Illustration of a damaged ribonucleic acid or  dna strand

BCH N of 1 Trial Yields Approved Therapy for Single Rare Disease Patient

The promise of precision medicine is focused on providing the right drug to the right patient at the right time. Usually that means matching...

Novartis Solicits Proposals to Advance Biomarker Testing in Cancer

Novartis is soliciting proposals from patient advocacy organizations for initiatives designed to expand and improve understanding of biomarker testing among people with cancer that...
With NGS diagnostics

Illumina and Qiagen Enter 15-Year Diagnostics Partnership

Two leaders in genomics and molecular analysis, Illumina and QIAGEN, have announced a 15-year partnership that the companies say is aimed at increasing the...

UTC/RenRX, 3 Principals Agree to Pay $42.6M to Settle False Claims Allegations

UTC Laboratories—also known as Renaissance RX (RenRX)—and its three principals have agreed to pay a combined $42.6 million to settle federal allegations that they...

Antimicrobial Resistance Test Kits, Blood Collection Tube

Streck has introduced three new antibiotic resistance detection kits. The new Streck ARM-D Kits detect the most clinically important current and emerging antimicrobial resistance...
Next-Generation Sequencing Test for Cutaneous Melanoma

Single-Cell Transcriptional Analysis Predicts Melanoma Drug Response

Investigators at the Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence have just released findings from a new study...
Provista Diagnostics researchers say the company's Videssa® Breast test can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce the use of traditional biopsy by up to 67%. (Source: [iStock/David Marchal)

Sequencing Method that Maps Breast Cell Differentiation Provides Insight to Cancer Development

Salk Institute researchers have used of a state-of-the-art technology known as single-nucleus (sn) assay for transposase-accessible chromatin (ATAC) sequencing (snATAC-seq) to profile how specific...
Centogene’s CentoMD® rare disease variant database will be integrated into Qiagen’s bioinformatics suite in a rare disease bioinformatics collaboration by the companies. [Source: alengo/Getty]

NIH Commits $38M to Rare Disease Research and Affiliated Data Center

About $31 million in grants has been awarded by The National Institutes of Health in fiscal year 2019 to 20 teams in order to...
DNA research concept DNA barcodes for biomedical research  mitochondrial DNA  Prostate cancer DNA test

8 Companion Diagnostic Developers Making a Mark

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
Stomach Ache Problem

Takeda, Prometheus Enter IBD Drug-Companion Diagnostic Partnership

Prometheus Biosciences said its bioinformatics platform and advanced machine learning techniques will be used by Takeda Pharmaceutical as part of a global collaboration to...
Verge Genomics has raised $32 million in Series A financing toward further development of new treatments by combining machine learning and neuroscience with experimental biology. [Source: kentoh/Getty Images]

Novartis, with Assist from Microsoft, Launches AI Innovation Lab

Novartis will establish an “AI innovation lab” designed to enable its research and commercial employees to use Microsoft’s artificial intelligence solutions across operations, with...
Source: chombosan/Getty Images

Point-of-Care Testing Revs Up

A host of new technologies and tests are allowing faster diagnosis and improved patient care across a range of conditions
Diabetes mellitus metabolic disease signs and symptoms concept, 3D rendering

Actionable Type 2 Diabetes Risks Uncovered

More than 67 actionable clinical discoveries were made through deep longitudinal genomic analysis by a group led by Michael Snyder, MD, chair of the...
Source: Meletios Verras/Getty Images

CRISPR/Cas9 Can Create Killer T Cells Highly Sensitive to Cancer Cell Antigens

The engineered killer T cells are 1,000 times more sensitive to cancer cell antigens to allow much better targeting to cancer cell lines
Source:Jill Lehmann Photography/Getty Images

Blood Test Identifies Preterm Birth Risk of Expectant Mothers

Stanford team IDs three sets of cfDNA in blood of pregnant women that measures risk of preterm delivery up to two months ahead of labor
Invitae lab

Search and Detect (for Free): Invitae Pursues Sponsors for Free Genetic Testing Programs Targeting...

Among the challenges long faced by diagnostics developers striving to broaden the use of their tests is finding enough patients to generate enough samples,...

GRAIL’s New Blood-Based Cancer Screening Test Shows High Sensitivity and Specificity

Dana-Farber Cancer Institute researchers report the development of a new blood test that has shown the ability in a multi-center trial to screen for...
Salim Essakali

Study Confirms Clinical Utility of Qiagen NGS Reader

Qiagen's GeneReader NGS system confirmed for detecting gene variants clinically relevant in detecting colorectal cancer.
DNA Capsules

Proper Prescribing: Pharmacogenetics Testing Gains Traction but Requires a Delicate Balancing Act

Pharmacogenomic testing is gaining traction, but incorporating it into the clinical setting with high fidelity requires a delicate balance.
DNA Test Sanger Sequencing

Ending the Odyssey: Leveraging Improved Sequencing Technology, Rare Disease Diagnosis Speeds Up and Spreads...

Leveraging improvements in sequencing technology that increase speed and lower costs, rare disease diagnostics broadens its reach.
These cramps are getting worse now

Gut Immune Cell Clock Genes Disruption Linked to IBD, Immune Control

Two independent sets of research published in Science Immunology have demonstrated how a subset of immune cells in the gut, known as group 3...
The U.S. Department of Veterans Affairs (VA) and IBM Watson Health have extended their two-year-old precision oncology partnership

IBM Watson, VA Extend AI-Driven Precision Oncology Collaboration

The two-year-old program, which has provided precision oncology care to 2,700 veterans with stage 4 cancer, will be extended to June 2019
Source: ChrisChrisW/Getty Images

First Use of Fecal Transplant to Treat Immunotherapy-Induced Colitis Reported

MD Anderson researchers suggest that fecal microbiota transplantation can be an effective treatment for the common side effect of ICIs

Veracyte, J&J Collaborate on Early Lung Cancer Detection

The deal will combine a 5,000-patient clinical cohort and outcome data with data derived from Veracyte's bronchial and nasal samples
Scroll Up